AI Verdict
MDT has stronger fundamentals based on our AI analysis.
ABT vs MDT Fundamental Comparison
| Metric | ABT | MDT |
|---|---|---|
| Revenue | $44.3B | $26.6B |
| Net Income | $6.5B | $3.6B |
| Net Margin | 14.7% | 13.4% |
| ROE | 12.5% | 7.3% |
| ROA | 7.5% | 3.9% |
| Current Ratio | 1.58x | 2.54x |
| Debt/Equity | 0.25x | 0.57x |
| EPS | $3.72 | $2.76 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABT vs MDT: Frequently Asked Questions
Is ABT or MDT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MDT has stronger fundamentals. ABT is rated BUY (77% confidence) while MDT is rated BUY (80% confidence). This is not investment advice.
How does ABT compare to MDT fundamentally?
ABBOTT LABORATORIES has ROE of 12.5% vs Medtronic plc's 7.3%. Net margins are 14.7% vs 13.4% respectively.
Which stock pays higher dividends, ABT or MDT?
ABT has a dividend yield of N/A or no dividend while MDT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABT or MDT for long term?
For long-term investing, consider that ABT has BUY rating with 77% confidence, while MDT has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABT vs MDT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs MDT, the AI consensus favors MDT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.